Skip to content

NuSkin Enterprises NUS Deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested

Deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested at other companies

Phillips 66 logo
Phillips 66PSX
$1.77B+1.2%
HTF
Heartflow, Inc. Common StockHTFL
$0
Jerash Holdings (US), Inc. logo
Jerash Holdings (US), Inc.JRSH
$17.6M+17.3%
Minerals Technologies logo
Minerals TechnologiesMTX
$0
Parker-Hannifin logo
Parker-HannifinPH
$17M+6.3%
Parker-Hannifin logo
Parker-HannifinPH
$16M+14.3%

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested?
NuSkin Enterprises (NUS) reported deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested of $6M in Q4 2025.
How has NuSkin Enterprises's deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested changed year-over-year?
NuSkin Enterprises's deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested decreased by 0.0% year-over-year, from $6M to $6M.
What is the long-term trend for NuSkin Enterprises's deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested?
Over 5 years (2020 to 2025), NuSkin Enterprises's deferred tax liabilities not recognized to unremitted earnings indefinitely reinvested has grown at a 0.0% compound annual growth rate (CAGR), from $6M to $6M.